Results for astrazeneca

Add to feed Create your own feed


Innate courting success despite split decision on milestone in Astrazeneca deal? Jury’s out

AstraZeneca: No link between adverse reactions and COVID-19 vaccine

Under pressure, Pfizer, Moderna (and soon AstraZeneca) publish COVID-19 vaccine protocols

So once AstraZeneca publishes their #COVID19  trial design, that has to make this the industry standard. Everyone has to follow through, right?

These growing calls for transparency have led Moderna, swiftly followed by Pfizer/BioNTech (and a pledge from AstraZeneca), to release their protocols this week, all of which are in the later stages of testing and likely to see datain the coming months.

$AZN: AstraZeneca: LYNPARZA improved median time patients lived without disease progression to over four and half...

$AZN: AstraZeneca: IMFINZI Demonstrated unprecedented survival in unresectable stage III non-small cell lung cancer...

We're looking for the AstraZeneca protocol 'shortly', while experts debate merits of Pfizer v Moderna

AstraZeneca’s Imfinzi Trial Shows Survival In Lung Cancer Patients $AZN


Most relevant

Drug giant AstraZeneca said it had paused a trial of its coronavirus vaccine because of an unexplained illness in one of the volunteers. It’s a standard precaution, meant to ensure experimental vaccines don’t cause serious reactions among volunteers.

BREAKING: AstraZeneca's #Covid19  vaccine trials have been paused as the company investigates a serious adverse event the occurred in the UK. Not clear if the unexplained illness is linked to the vaccine, or what it was.

JUST IN: AstraZeneca has put its phase three vaccine trial on hold due to an unexplained illness in a participant

Breaking News: A major coronavirus vaccine trial was halted because of a serious adverse reaction in a participant, the pharmaceutical company AstraZeneca said.

President @realDonaldTrump  just announced that AstraZeneca's vaccine has reached Phase 3 clinical trials!

Coronavirus vaccines in stage three testing: Murdoch Institute and University of Melbourne - AustraliaSinovac - ChinaSinoPharm - China AstraZeneca and Oxford - UK Moderna and NIAID - US (starting 27th of July)

First human trial of AstraZeneca COVID-19 vaccine shows promise

JUST IN: A coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc showed promising results in early human testing, a sign of progress in the high-stakes pursuit of a shot to defeat the pathogen

tweet picture

This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering.

AstraZeneca and the University of Oxford are teaming up to develop and manufacture a vaccine for coronavirus with the aim of building capacity to produce 100m doses by the end of the year if it is shown to be effective